Congress allows Washington DC medical cannabis reforms to become law

March 24, 2023 · MJ Biz Daily

Medical cannabis is expected to be much more easily and widely available in Washington DC after a set of reforms that include lifting a cap on dispensaries and allowing patients to “self-certify” became law this week.

Congress had until March 22 to interfere with the Medical Cannabis Amendment Act signed into by Washington DC Mayor Muriel Bowser in January, but the federal lawmakers took no action, according to NORML.

In addition to allowing residents to “self-certify” as medical-cannabis patients, which some observers say amounts to a de facto adult-use market, the new law:

  • Eliminates a cap on the number of dispensaries allowed in the district.
  • Temporarily lifts plant limit for licensed cultivators.
  • Allows for delivery services and consumption lounges.
  • Extends limited tax relief to operators.

“Despite being under the thumb of Congressional lawmakers, members of the DC City government continue to prioritize policies that both advance and protect the freedoms of responsible cannabis consumers,” Paul Armentano, NORML’s deputy director, said in a statement.

Separately, the DC City Council passed an expungement law that’s supposed to clear records of certain low-level convictions by Jan. 1, 2025.

Voters in the nation’s capital legalized adult-use cannabis in 2014, but the only legal access to marijuana is via MMJ dispensaries.

Past efforts to regulate adult-use retail have been blocked by Congress, which has veto power over local laws under the district’s Home Rule Act.

In the interim, illicit cannabis sales have flourished.

Meanwhile, D.C. dispensaries and cultivation centers reported $4.7 million in monthly sales in February 2023. (Full Story)

In categories:Federal Policy Politics
Next Post

Oregon Company Defends Federal Lawsuit Challenging The State’s Ban On Cannabis Exports

An Oregon marijuana business challenging the state’s ban on interstate cannabis commerce asked a federal judge last week to allow the case to be heard in court, arguing that the company has a “right to operate its business—federally legal or…
Read
Previous Post

Bipartisan Senators File Bill To Ease Restrictions On Industrial Hemp Farmers

A bipartisan pair of U.S. senators have filed a bill to reduce regulations on farmers that grow industrial hemp for non-extraction purposes. Sens. Jon Tester (D-MT) and Mike Braun (R-IN) introduced the Industrial Hemp Act on Thursday—the latest piece of…
Read
Random Post

Missouri Cannabis Rollout Under Fire for Exclusion of Some Incarceration Data

The agency examined incarceration rates over the past 20 years, which ignored data from the 1980s. The United States’ War on Drugs spans decades, but Missouri’s licensing process failed to consider much of the impact the policy had on disadvantaged communities,…
Read
Random Post

Regulations Are Out of Step with Economic Reality

Despite all the hype and optimism that characterized the initiation of adult-use legalization, the past ten years of both business and tax revenues have fallen far short of investor and analyst projections. Today, companies of all sizes are struggling to…
Read
Random Post

Wisconsin governor still dedicated to marijuana legalization

Wisconsin Gov. Tony Evers is still committed to legalizing marijuana, even though his latest attempt was shot down earlier this year by state Republican legislators. Evers said this week that an “overwhelming majority of Wisconsinites support” regulating cannabis like alcohol, according to…
Read
Random Post

Psychedelic API Market To Reach $6.1B By 2033 Boosted By LSD: New Analysis

The psychedelic Active Pharmaceutical Ingredient (API) Market, currently estimated at $1.6 billion, is expected to rise at a CAGR of 13.2% over the next ten years and be worth $6.1 billion by the end of 2033. That's according to Persistence Market…
Read